Fibroblast‐specific integrin‐alpha V differentially regulates type 17 and type 2 driven inflammation and fibrosis-Reference-Cited by-同舟云学术

Fibroblast‐specific integrin‐alpha V differentially regulates type 17 and type 2 driven inflammation and fibrosis

Published:2019-01-24 Issue:1 Volume:248 Page:16-29
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Sciurba Joshua C¹^ORCID,Gieseck Richard L¹,Jiwrajka Nikhil¹,White Sandra D¹,Karmele Erik P¹,Redes Jamie²,Vannella Kevin M¹,Henderson Neil C³,Wynn Thomas A¹,Hart Kevin M¹

Affiliation:

1. Immunopathogenesis Section, Laboratory of Parasitic DiseasesNational Institute of Allergy and Infectious Diseases, National Institutes of Health Bethesda MD USA

2. MRC Centre for Inflammation Research, Centre for Multiple Sclerosis Research, BHF Centre for Cardiovascular Science, and Centre for Immunity Infection and EvolutionUniversity of Edinburgh Edinburgh UK

3. Molecular Signal Transduction Section, Laboratory of Allergic DiseasesNational Institute of Allergy and Infectious Diseases, National Institutes of Health Bethesda MD USA

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.5215

Reference59 articles.

1. The Myofibroblast

2. TGF-β: the master regulator of fibrosis

3. Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients